Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000288091

Medchemexpress LLC (2S)-N-[7-chloro-6-[4-[(3R,4R)-4-hydroxy-3-methyloxolan-3-yl]piperazin-1-yl]isoquinolin-3-yl]-6-o... | 2769107-89-1 | 99.7% | 501.02 g·mol⁻1 | C26H33ClN4O4 | 10 MG
SDP

Catalog No. 5000288091
Encompass_Preferred

MK-1468 is an orally active, selective, blood-brain barrier-permeable inhibitor of leucine-rich repeat kinase 2 (LRRK2) used in preclinical research of Parkinson's disease and LRRK2-related pathways.

  • Orally active and brain-penetrant LRRK2 inhibitor suitable for in vivo and in vitro studies.
  • High purity (≈99.7%) for research-grade experiments.
  • Molecular weight 501.02 g·mol⁻1 and formula C26H33ClN4O4.
  • Available in small-scale quantities for dosing and assay optimization.
  • Store powder at -20°C; solutions stable at -80°C for 6 months.

Catalog No. 50-002-88091 Supplier Medchemexpress LLC Supplier No. HY15642910MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

MK-1468 is an orally active, selective, blood-brain barrier-permeable inhibitor of leucine-rich repeat kinase 2 (LRRK2) used in preclinical research of Parkinson's disease and LRRK2-related pathways.

  • Orally active and brain-penetrant LRRK2 inhibitor suitable for in vivo and in vitro studies.
  • High purity (≈99.7%) for research-grade experiments.
  • Molecular weight 501.02 g·mol⁻1 and formula C26H33ClN4O4.
  • Available in small-scale quantities for dosing and assay optimization.
  • Store powder at -20°C; solutions stable at -80°C for 6 months.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.